Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience
Gao, J, He, Q, Subudhi, S, Aparicio, A, Zurita-Saavedra, A, Lee, D H, Jimenez, C, Suarez-Almazor, M, Sharma, P
Published in Oncogene (01.10.2015)
Published in Oncogene (01.10.2015)
Get full text
Journal Article
Testosterone Recovery and Associated Impact on Patient-Reported Health-Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial
Moningi, S., Nguyen, P.L., Rathkopf, D., Zurita-Saavedra, A., Spratt, D.E., Dess, R.T., Liauw, S., Szmulewitz, R., Einstein, D.J., Bubley, G., Yu, J.B., An, Y., Wong, A.C., Feng, F.Y., Mckay, R.R., Rose, B.S., Shin, K.Y., Taplin, M.E.A., Kollmeier, M.A., Hoffman, K.E.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide after Radical Prostatectomy
Hoffman, K.E., Nguyen, P.L., Rathkopf, D., Zurita-Saavedra, A., Spratt, D.E., Dess, R.T., Liauw, S., Szmulewitz, R., Einstein, D.J., Bubley, G., Yu, J.B., An, Y., Wong, A.C., Feng, F.Y., Mckay, R.R., Rose, B.S., Lee, K.Y., Kibel, A., Taplin, M.E.A., Kollmeier, M.A.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)
Nguyen, P.L., Kollmeier, M.A., Rathkopf, D., Hoffman, K.E., Zurita-Saavedra, A., Spratt, D.E., Dess, R.T., Liauw, S., Szmulewitz, R., Einstein, D.J., Bubley, G., Yu, J.B., An, Y., Wong, A.C., Feng, F.Y., Mckay, R.R., Rose, B.S., Shin, K.Y., Kibel, A., Taplin, M.E.A.
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Get full text
Journal Article
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
Tang, C., Sherry, A.D., Haymaker, C., Bathala, T., Liu, S., Fellman, B., Aparicio, A., Zurita-Saavedra, A., Chun, S.., Reddy, J., Efstathiou, E., Wang, J., Pilie, P., Reuben, A., Kovitz, C., Kumar, R., Chapin, B., Gomez, D.R., Wistuba, I., Corn, P.G.
Published in International journal of radiation oncology, biology, physics (01.12.2022)
Published in International journal of radiation oncology, biology, physics (01.12.2022)
Get full text
Journal Article
Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial
Sherry, A.D., Haymaker, C., Bathala, T., Lu, X., Medina-Rosales, M., Marmonti, E., Pradeep, H., Liu, S., Fellman, B., Mok, H., Choi, S., Chun, S.G., Aparicio, A., Kovitz, C., Zurita-Saavedra, A., Gomez, D.R., Reuben, A., Wistuba, I., Corn, P.G., Tang, C.
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Get full text
Journal Article
Lenvatinib (Len) alone or in combination with everolimus (Eve) in heavily pretreated patients (pts) with metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitors (ICI) and VEGFR-targeted therapies: A single-institution experience
Wiele, A.J., Ross, J., Chahoud, J., Lim, Z., Xiao, L., Campbell, M.T., Shah, A.Y., Zurita Saavedra, A., Jonasch, E., Tannir, N.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
964P - Lenvatinib (Len) alone or in combination with everolimus (Eve) in heavily pretreated patients (pts) with metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitors (ICI) and VEGFR-targeted therapies: A single-institution experience
Wiele, A.J., Ross, J., Chahoud, J., Lim, Z., Xiao, L., Campbell, M.T., Shah, A.Y., Zurita Saavedra, A., Jonasch, E., Tannir, N.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
964PLenvatinib (Len) alone or in combination with everolimus (Eve) in heavily pretreated patients (pts) with metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitors (ICI) and VEGFR-targeted therapies: A single-institution experience
Wiele, A J, Ross, J, Chahoud, J, Lim, Z, Xiao, L, Campbell, M T, Shah, A Y, Zurita Saavedra, A, Jonasch, E, Tannir, N M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Definitive Radiotherapy for Oligoprogressive Metastatic Renal Cell Carcinoma as a Strategy to Defer Systemic Therapy Escalation
De, B., Venkatesan, A., Msaouel, P., Ghia, A.J., Li, J., Yeboa, D.N., Nguyen, Q.N., Bishop, A.J., Jonasch, E., Shah, A.Y., Campbell, M., Wang, J., Zurita-Saavedra, A., Karam, J., Wood, C., Matin, S., Tannir, N., Tang, C.
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Get full text
Journal Article
UFT-induced haemolytic anaemia
ZURITA, Amado J, MATILDE, Saavedra, GARCIA, Navarro, ESPANOL, Ignacio, FERNANDEZ ORTEGA, Adela
Published in Cancer chemotherapy and pharmacology (01.03.2001)
Published in Cancer chemotherapy and pharmacology (01.03.2001)
Get full text
Journal Article
Outcomes of patients with metastatic renal cell carcinoma (mRCC) who were treated with second-line (2L) vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKI) after first-line (1L) immune checkpoint inhibitor (ICI) therapy
Shah, A.Y., Lemke, E.A., Jianjun, G., Chandamohan, A., Campbell, M.T., Zurita Saavedra, A., Xiao, L., Wang, J., Corn, P.G., Jonasch, E., Sharma, P., Tannir, N.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
1186PDSafety and efficacy of the oral CXCR4 inhibitor X4P-001 + axitinib in advanced renal cell carcinoma patients: An analysis of subgroup responses by prior treatment
McDermott, D F, Vaishampayan, U, Matrana, M, Rha, S Y, Saavedra, A Zurita, Ho, T, Keam, B, Lee, J-L, Joseph, R, Ali, S, Stadler, W, Haas, N B, Sundararajan, S, Park, S H, Mowat, R, Picus, J, Dudek, A Z, Zakharia, Y, Gan, L, Atkins, M B
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1186PD - Safety and efficacy of the oral CXCR4 inhibitor X4P-001 + axitinib in advanced renal cell carcinoma patients: An analysis of subgroup responses by prior treatment
McDermott, D.F., Vaishampayan, U., Matrana, M., Rha, S.Y., Saavedra, A Zurita, Ho, T., Keam, B., Lee, J.-L., Joseph, R., Ali, S., Stadler, W., Haas, N.B., Sundararajan, S., Park, S.H., Mowat, R., Picus, J., Dudek, A.Z., Zakharia, Y., Gan, L., Atkins, M.B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Safety and efficacy of the oral CXCR4 inhibitor X4P-001 + axitinib in advanced renal cell carcinoma patients: An analysis of subgroup responses by prior treatment
McDermott, D.F., Vaishampayan, U., Matrana, M., Rha, S.Y., Saavedra, A Zurita, Ho, T., Keam, B., Lee, J.-L., Joseph, R., Ali, S., Stadler, W., Haas, N.B., Sundararajan, S., Park, S.H., Mowat, R., Picus, J., Dudek, A.Z., Zakharia, Y., Gan, L., Atkins, M.B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Multivariate Analysis of Cytokines and Angiogenic Factors (CAFS) and Established Prognostic Parameters in Metastatic Renal Cell Carcinoma (MRCC) Patients (PTS) Receiving Pazopanib or Placebo
Zurita-Saavedra, A., Liu, Y., Lin, Y., Tran, H.T., Pandite, L.N., Heymach, J.V.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article